HLS Therapeutics (TSX:HLS) Accounts Payable : C$17.77 Mil (As of Mar. 2024)

View and export this data going back to 1959. Start your Free Trial

What is HLS Therapeutics Accounts Payable?

HLS Therapeutics's Accounts Payable for the quarter that ended in Mar. 2024 was C$17.77 Mil.

HLS Therapeutics's quarterly Accounts Payable declined from Sep. 2023 (C$18.96 Mil) to Dec. 2023 (C$18.93 Mil) and declined from Dec. 2023 (C$18.93 Mil) to Mar. 2024 (C$17.77 Mil).

HLS Therapeutics's annual Accounts Payable increased from Dec. 2021 (C$11.92 Mil) to Dec. 2022 (C$15.75 Mil) and increased from Dec. 2022 (C$15.75 Mil) to Dec. 2023 (C$18.93 Mil).

HLS Therapeutics Accounts Payable Historical Data

The historical data trend for HLS Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLS Therapeutics Accounts Payable Chart

HLS Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

17.73

11.76

11.92

15.75

18.93

HLS Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															18.11	17.17	18.96	18.93	17.77

HLS Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

HLS Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of HLS Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

HLS Therapeutics (TSX:HLS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (TSX:HLS) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

HLTRF:USA

Address

10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W6L2

Website

https://www.hlstherapeutics.com

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, Trinomia, and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of the world.

Executives

Polar Asset Management Partners Inc.

10% Security Holder

HLS Therapeutics (TSX:HLS) Headlines

No Headlines